New hope for ALS patients: experimental drug shows promise in early trial
Disease control
Completed
This study tested an experimental drug called IFB-088 added to the standard ALS medication riluzole in 51 people with bulbar-onset ALS (a form that first affects speech and swallowing). The goal was to see if the combination is safe and shows signs of slowing the disease. Partici…
Phase: PHASE2 • Sponsor: InFlectis BioScience • Aim: Disease control
Last updated May 08, 2026 12:03 UTC